113 related articles for article (PubMed ID: 17105614)
1. Maximum donation volumes per session in donor plasmapheresis.
Karger R; Kretschmer V
Vox Sang; 2006 Nov; 91(4):350; author reply 351-2. PubMed ID: 17105614
[No Abstract] [Full Text] [Related]
2. Atrial natriuretic peptide serum concentration decreases in donors undergoing discontinuous plasmapheresis involving a large extracorporeal blood volume.
Karger R; Halbe M; Giffhorn-Katz S; Katz N; Kretschmer V
Transfusion; 2007 Sep; 47(9):1717-24. PubMed ID: 17725739
[TBL] [Abstract][Full Text] [Related]
3. Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule.
Fed Regist; 1981 Nov; 46(226):57480-1. PubMed ID: 10253366
[TBL] [Abstract][Full Text] [Related]
4. Donor safety in plasmapheresis.
Lundsgaard-Hansen P
Dev Biol Stand; 1980; 48():287-95. PubMed ID: 7274560
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulation, bleeding, and clotting at donor plasmapheresis.
Evers J; Taborski U
J Clin Apher; 2018 Aug; 33(4):538-540. PubMed ID: 29575131
[TBL] [Abstract][Full Text] [Related]
6. Current plasmapheresis practices in the United States.
Crispen JF
Dev Biol Stand; 1980; 48():297-301. PubMed ID: 7274561
[No Abstract] [Full Text] [Related]
7. Plasmapheresis in healthy donors in the Netherlands: cohort study of risk factors for donor complications.
Wiersum-Osselton JC; Marijt-van der Kreek T; van Dongen R
Transfus Apher Sci; 2013 Apr; 48(2):163. PubMed ID: 23809816
[No Abstract] [Full Text] [Related]
8. Blood volumes of Pakistani male donors: implications for blood donation.
Salamat N
J Ayub Med Coll Abbottabad; 2007; 19(3):30-3. PubMed ID: 18444587
[TBL] [Abstract][Full Text] [Related]
9. CMV antibody prevalence and seroincidence in plateletpheresis donors.
Boeke CE; Pauly ME; Hatch-Stock H; Jackson JB
J Clin Apher; 2008; 23(2):63-5. PubMed ID: 18181166
[TBL] [Abstract][Full Text] [Related]
10. Safeguards for plasma donors in plasmapheresis programs.
JAMA; 1970 Aug; 213(5):743-7. PubMed ID: 5468413
[No Abstract] [Full Text] [Related]
11. Plasmcapheresis--principles and practice.
Jacob CK
J Indian Med Assoc; 2001 Jul; 99(7):364-7. PubMed ID: 11881846
[TBL] [Abstract][Full Text] [Related]
12. Adaptation of the Bio-Rad protein microassay to a 96 well microtitre procedure for monitoring plasmapheresis donors.
Howie RI; Murray SA; Wasi S
Transfusion; 1989; 29(6):561-2. PubMed ID: 2749883
[No Abstract] [Full Text] [Related]
13. Volume limitations of plasmapheresis.
Lundsgaard-Hansen P
Vox Sang; 1977; 32(1):20-5. PubMed ID: 320764
[TBL] [Abstract][Full Text] [Related]
14. Federal regulation of commercial plasmapheresis centers.
Solomon JM
J Clin Apher; 1985; 2(4):368-71. PubMed ID: 4066634
[No Abstract] [Full Text] [Related]
15. Plasmapheresis operations in the United States--1968.
Hartney JB
JAMA; 1970 Aug; 213(6):1023-5. PubMed ID: 5468172
[No Abstract] [Full Text] [Related]
16. [The electrolyte content of donor blood in frequently repeated plasmapheresis].
Gutnik RB; Zinevich AK
Vrach Delo; 1968 Feb; 2():150-1. PubMed ID: 5669350
[No Abstract] [Full Text] [Related]
17. [Effect of plasmapheresis on the protein-synthetic function of the liver and several immunologic indices of reactivity of the donor organism].
Konstantinov VN
Probl Gematol Pereliv Krovi; 1970 Jul; 15(7):50-1. PubMed ID: 5484235
[No Abstract] [Full Text] [Related]
18. [Genetic hemochromatosis and blood donation].
Courtois F; Danic B;
Ann Med Interne (Paris); 2001 Nov; 152(7):452-4. PubMed ID: 11965086
[No Abstract] [Full Text] [Related]
19. Retention of prospective donors: a survey about services at a blood donation centre.
Moog R
Transfus Apher Sci; 2009 Jun; 40(3):149-52. PubMed ID: 19362518
[TBL] [Abstract][Full Text] [Related]
20. Platelet transfusion procedures. Platelet Transfusion Subcommitte of the Acute Leukemia Task Force.
Cancer Chemother Rep 3; 1968 Dec; 1(1):1-12. PubMed ID: 5212270
[No Abstract] [Full Text] [Related]
[Next] [New Search]
